rac-1-(5-fluoro-2-(1-(2-fluorobenzyl)-5-(isoxazol-3-yl)-1H-pyrazol-3-yl)pyrimidin-4-yl)piperidin-3-ol

ID: ALA4865595

Chembl Id: CHEMBL4865595

PubChem CID: 86267930

Max Phase: Preclinical

Molecular Formula: C22H20F2N6O2

Molecular Weight: 438.44

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  OC1CCCN(c2nc(-c3cc(-c4ccon4)n(Cc4ccccc4F)n3)ncc2F)C1

Standard InChI:  InChI=1S/C22H20F2N6O2/c23-16-6-2-1-4-14(16)12-30-20(18-7-9-32-28-18)10-19(27-30)21-25-11-17(24)22(26-21)29-8-3-5-15(31)13-29/h1-2,4,6-7,9-11,15,31H,3,5,8,12-13H2

Standard InChI Key:  NNTBSIOGAGORIE-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4865595

   1-[5-Fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperidin-3-ol

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 438.44

Molecular Weight (Monoisotopic): 438.1616

AlogP: 3.28

#Rotatable Bonds: 5

Polar Surface Area: 93.10

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 0.73

CX LogP: 4.10

CX LogD: 4.10

Aromatic Rings: 4

Heavy Atoms: 32

QED Weighted: 0.51

Np Likeness Score: -1.65

References

1. Rennie GR, Barden TC, Bernier SG, Carvalho A, Deming R, Germano P, Hudson C, Im GJ, Iyengar RR, Jia L, Jung J, Kim E, Lee TW, Mermerian A, Moore J, Nakai T, Perl NR, Tobin J, Zimmer DP, Renhowe PA..  (2021)  Discovery of CYR715: A novel carboxylic acid-containing soluble guanylate cyclase stimulator.,  40  [PMID:33662540] [10.1016/j.bmcl.2021.127886]

Source

Source(1):

• Scientific Literature